Literature DB >> 3429442

Antibody to platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF).

K Karasawa1, K Fujita, N Satoh, T Hongo, M Setaka, M Ohno, S Nojima.   

Abstract

Specific antibodies to platelet activating factor (PAF) were prepared by immunizing rabbits with a hapten-bovine serum albumin (BSA) conjugate. As the hapten we used the synthetic PAF derivative which is resistant against enzymatic inactivation by plasma or tissues and which can bind to BSA through covalent bonding. Antibody activity was determined by an enzyme-linked immunosorbent assay (ELISA). Anti-PAF IgG reacted strongly with PAF. By means of the ELISA inhibition assay, we found that the antibody did not cross-react with phosphocholine, glycerophosphocholine, dilaurylglycerophosphocholine or PAF analogues which have ethanolamine-type polar head groups instead of choline group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3429442     DOI: 10.1093/oxfordjournals.jbchem.a122075

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  4 in total

1.  Radioimmunoassay for platelet-activating factor.

Authors:  K Karasawa; N Satoh; T Hongo; Y Nakagawa; M Setaka; S Nojima
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  A sensitive and specific radioimmunoassay for platelet-activating factor.

Authors:  C Wang; H H Tai
Journal:  Lipids       Date:  1992-03       Impact factor: 1.880

3.  Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.

Authors:  K Karasawa; N Satoh; T Hongo; Y Nakagawa; M Setaka; S Nojima
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Synthesis of a PAF immunogen and production of PAF-specific antibodies.

Authors:  M A Smal; B A Baldo; J W Redmond
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.